Directorate Change

12 June 2013

                          Reckitt Benckiser Group plc                          

                              DIRECTORATE CHANGE                               

It is with regret that Reckitt Benckiser Group plc (RB) today announces the
resignation of Graham Mackay as a director, and the Senior Independent
Director, with immediate effect.


As was announced by SABMiller plc in April, Mr Mackay has recently undergone
surgery for a brain tumour and is now receiving further treatment. As a result,
Mr Mackay has expressed a wish to reduce his business commitments and has
tendered his resignation to the RB Board.

Adrian Bellamy, Chairman of RB, commented:

"Graham has been a valued member of our Board and our Remuneration Committee
since February 2005 and we thank him for his immense contribution and wise
counsel over the last eight years. We also thank him for acting as our Senior
Independent Director since November 2006. We fully respect and understand his
decision to step down from the Board and I, on behalf of the Board and I am
sure also on behalf of our shareholders, wish him well as he continues his
treatment. Our thoughts are with him and his family."

Following Mr Mackay's resignation, with immediate effect the Board has
appointed Andre Lacroix as the new Senior Independent Director. Mr Lacroix, the
current CEO of Inchcape plc, has been a director of RB since October 2008 and
is a member of the Audit Committee.

For further information:

Elizabeth Richardson

Company Secretary

Telephone [phone]

Notes for Editors:

Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and
home.

With a purpose of delivering innovative solutions for healthier lives and
happier homes, RB is in the top 25 of companies listed on the London Stock
Exchange. Today it is the global No 1 or No 2 in the majority of its
fast-growing categories, driven by an exceptional rate of innovation. Its
health, hygiene and home portfolio is led by 19 global Powerbrands including
Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil,
Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, and
French's. RB has close to half of its revenues coming from it 2 emerging market
Areas and just over half from its developed market Area.

RB people and its culture are at the heart of the company's success. They have
an intense drive for achievement and a desire to outperform wherever they
focus, including in sustainability where the company has reduced its carbon
footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in
water impact, 1/3 further reduction in carbon and to have 1/3 of its net
revenue coming from more sustainable products by 2020. RB has been recognised
as a sustainability leader in the CDP Global 500 Carbon Performance Leadership
Index and received a 2013 Sector Mover Sustainability Award in the 10th
Sustainability Yearbook. It is also the Save the Children charity's largest
FMCG global partner.

The company has operations in over 60 countries, with headquarters in the UK,
Singapore, Dubai and Amsterdam, and sales in almost 200 countries, The company
employs approximately 36,000 people worldwide.

For more information visit www.rb.com